As IL-13 has been shown to affect infection outcomes following CDI [27], we assessed the functional role of ILC2 during early CR infection by injecting anti-IL-13 IP on days 2 and 4 post-infection (Fig 6A). The gene discussed is IL13; the disease is infection.